Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Metastatic Hormone-sensitive Prostate Cancer
Clinical Trial
NCT02799602Last updated: 1/13/2026
Colorectal Neoplasms
Pneumonia, Bacterial
Overactive Bladder
Chronic Kidney Disease
Oral Contraceptive